Our Board of Directors | AAM
In the News - AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.

Board of Directors

We invite you to meet our AAM Board of Directors. 

View Profiles


Company Board Member
Accord Healthcare, Inc. Jeff Hampton
American Regent  
Amneal Pharmaceuticals, Inc. Steve Manzano
Apotex Corporation Peter Hardwick
Aurobindo Pharma USA, Inc. Hunter Murdock
Cipla USA (InvaGen Pharmaceuticals, Inc.) Arunesh Verma
Dr. Reddy's Laboratories, Inc. Vanessa Brill
Fresenius Kabi USA John Ducker
Glenmark Pharmaceuticals, Inc., USA Sanjeev Krishnan
Greenstone LLC, a subsidiary of Pfizer Andrew Callos
Hikma Pharmaceuticals USA Brian Hoffmann
Jubilant Cadista Pharmaceuticals, Inc. Terrence Fullem
Kindeva Drug Delivery Aaron Mann
Lupin Inc. Alok Sonig (Chair)
Mallinckrodt Specialty Generics Spiro Gavaris
Mayne Pharma Group, Limited Daniel Moore
Rhodes Pharmaceuticals L.P. Vincent Mancinelli II
Sagent Pharmaceuticals Peter Kaemmerer
Sandoz Inc. Carol Lynch
Sun Pharmaceutical Industries, Inc. Uday Baldota
Teva Pharmaceuticals USA, Inc. George Keefe
Zydus Pharmaceuticals USA, Inc. Joe Renner


Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.